Pular para o conteúdo principal
Ranking Invest

PBH - Prestige Consumer Healthcare Inc.

Segmento: HealthcarePrestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Análise Ranking Invest

Valuation estimado
-10,67%
$ 2.20 Bi
Valor de Mercado
$ 2.22 Bi
Sobrepreço (AV)+1.1%
IVR
0.99A companhia vale 0,99 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.21O valuation alternativo equivale a 21% do valor de mercado da companhia.
MLL
0.21O lucro líquido dos controladores em 16 trimestres equivale a 21% do valor de mercado.
Último Balanço Atualizado: 1T2027

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.92 Bi

Dívida Líquida

$ 1.93 Bi

L4T

$ 172.01 Mi

MM4T

15.50%

Indicadores Básicos

ROE

8.97%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

A0.08

Margem

A0.08

Índices de Tendência

Receita Líquida

E-3.55

Lucro

F-6.39

Margem

F-6.12

Índices de Endividamento

DIV/PAT

1.01

DIV/L4T

11.21

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.